Meyron

Reference summary — not medical advice or a personal risk estimate.

Combined oral contraceptives

Group 1 — carcinogenic to humansMedications & MedicalbehavioralEvidence: sufficient_in_humans

Summary

Combined oral contraceptives are associated with slight increases in some cancers and reduced risk of others.

Detail

Estrogen-progestogen oral contraceptives are Group 1 with sufficient evidence for breast, cervix and liver cancer; they are also associated with reduced risk of ovarian, endometrial and colorectal cancer. The overall risk-benefit balance is individual; discuss with a clinician.

Regional relevance

global

global

Sources

Consumer references

Third-party tools some readers use alongside primary evidence. Meyron doesn't endorse them; we link them because you'll otherwise hit them anyway.